Aluminium Compounds: The Antiperspirant Actives Behind the Breast-Cancer Debate

What aluminium compounds are

"Aluminium compounds" on a label is a family name, not a single ingredient. The workhorses are aluminium chlorohydrate (often shortened to ACH), aluminium sesquichlorohydrate, and the aluminium zirconium complexes — aluminium zirconium trichlorohydrex gly, tetrachlorohydrex gly and their relatives — in which zirconium and the amino acid glycine are added to the aluminium salt to make it gentler on skin and less likely to stain. Aluminium chloride itself, a stronger and more irritating salt, is used mainly in clinical-strength and prescription-strength products rather than in everyday sticks. Spelling varies by country: the EU ingredient lists use "aluminium", the US drug labels use "aluminum", and the two spellings describe the same metal.

One naming trap is worth clearing up at the start. Aluminium is the third most abundant element in the Earth's crust, and it is everywhere in ordinary life — in food, drinking water, cookware, antacids and medicines — so the mere presence of aluminium in a product tells you nothing on its own. What matters, as with every ingredient on this site, is the form, the dose, the route into the body, and what the studies actually measured. An antiperspirant is the one cosmetic use where aluminium is deliberately applied to skin every day, in a concentrated salt, close to breast tissue — and that combination, not aluminium in general, is what the debate is about.

Why antiperspirants use them

First, the distinction that the whole article depends on: a deodorant deals with smell, and an antiperspirant deals with wetness. Sweat itself is nearly odourless; bacteria on the skin turn it into the smell we recognise. A deodorant attacks the bacteria or masks the smell. An antiperspirant goes one step further and reduces the sweat reaching the surface at all — and only aluminium salts do that job in a mainstream product.

The mechanism is physical, not hormonal. When an aluminium salt meets sweat, it dissolves and reacts with proteins in the sweat duct to form a gel-like plug that temporarily blocks the duct. The plug is shed as skin cells turn over, which is why antiperspirant has to be reapplied and why its effect fades over a day or two rather than switching off instantly. In the United States this sweat-blocking claim is what makes the product a drug: antiperspirants are regulated as over-the-counter drugs under 21 CFR Part 350, which lists the permitted aluminium actives and their maximum concentrations — aluminium chlorohydrate up to 25%, aluminium zirconium complexes up to 20%, aluminium chloride up to 15% in its aqueous form — and requires the familiar Drug Facts warnings. In the European Union the same products are regulated as cosmetics, with the safety assessment left to the scientific committee discussed below. Same salts, different legal boxes, and the label you read depends on which side of that divide your product was made for.

Tip: if a product promises "48-hour protection" or "clinical strength" without naming an aluminium salt in its active ingredients, read the claim again. Dryness claims of that kind are antiperspirant claims, and antiperspirant claims without an aluminium active are marketing, not chemistry.

Where you will find them

• Antiperspirant sticks, creams and roll-ons — the main use, where the aluminium salt is the active ingredient and usually appears near the top of the list
• Antiperspirant sprays — the same salts in aerosol form, where the EU safe level is expressed higher (10.60% elemental aluminium) because less of the spray reaches the skin
• Clinical-strength antiperspirants — higher-concentration aluminium chloride or chlorohydrate formulas, often applied at night, for people whose sweating is heavy enough to need them
• Lipsticks and toothpastes — aluminium compounds appear here too, but at far lower levels, and the EU assessment covers them separately from antiperspirants
• Products that are not antiperspirants at all — aluminium salts also appear as astringents and in water treatment, which is why "contains aluminium" on a safety data sheet is not the same claim as "contains an antiperspirant active"

Related: Best Deodorant Without Aluminium: What Actually Works, and What to Expect — the companion guide for readers who want odour control without blocking sweat.

The concern: breast cancer, Alzheimer's, kidneys and skin

The concern about aluminium compounds has four strands, and they differ wildly in strength. The first, and the one that drives most avoidance, is breast cancer. It rests on three observations: antiperspirants are applied daily next to breast tissue; aluminium has been measured in breast tissue; and in laboratory dishes, aluminium salts can interfere with oestrogen receptors in human breast cancer cells. Philippa Darbre's 2005 study showed that aluminium chloride and aluminium chlorohydrate interfered with oestrogen-receptor function in MCF7 breast cancer cells, adding aluminium to the list of metals called metalloestrogens. Two years later, Exley and colleagues measured aluminium in breast tissue from mastectomies and found significantly higher levels in the outer regions of the breast (near the underarm) than in the inner regions — a finding the authors themselves left open, noting that whether the distribution relates to the higher incidence of tumours in the upper outer quadrant "remains to be ascertained". The American Cancer Society's answer to that last point is worth hearing in full: about half of breast cancers start in the upper outer area, most likely because there is simply more breast tissue there, so the geography alone proves nothing.

The second strand is Alzheimer's disease. Aluminium is a known systemic toxicant at high doses, and aluminium has been found in the plaques characteristic of Alzheimer's disease. The question has been investigated for decades, and the EU summaries report no reliable indications of a causal association between aluminium exposure and neurodegenerative disease. Presence in a diseased tissue is not the same as causation — a distinction that matters here, because it is the same error that runs through much of the breast-cancer coverage: finding a substance in a tumour, or in a diseased brain, does not show that the substance caused the disease, especially when the substance is also present in healthy tissue and in the wider environment.

The third strand is kidneys, and it is the one with a real label behind it. The story starts in dialysis, not in cosmetics: dialysis patients were once given aluminium hydroxide to control blood phosphorus, and because their kidneys could not clear aluminium, it accumulated and was linked to dementia and a form of bone disease. That history is why US antiperspirant labels must warn users to ask a doctor before use if they have kidney disease. The National Kidney Foundation is blunt about the scale: the warning is aimed at people whose kidneys function at 30% or less, and it is almost impossible to absorb enough aluminium through the skin to harm healthy kidneys. The warning is real, and its scope is narrow — both facts at once.

The fourth strand is the most ordinary and the most certain: skin irritation. Aluminium salts, particularly the stronger chloride forms and higher-concentration formulas, can irritate underarm skin, especially freshly shaved skin — which is why the same US labels also say not to use the product on broken skin and to stop use if a rash or irritation develops. Irritation is not a cancer signal, but it is the reason many people actually stop using a particular antiperspirant, and it deserves its place in the list rather than being crowded out by the bigger, unproven worries.

What regulators and reviewers say

In the European Union, the story runs in two acts. In 2014 the Scientific Committee on Consumer Safety (SCCS) issued opinion SCCS/1525/14 and concluded that, because of a lack of adequate data on dermal penetration, it could not perform a risk assessment for aluminium in cosmetics at all — an honest "we do not know yet" that is rarer in regulatory documents than it should be. Industry then funded a human exposure study, and in March 2020 the SCCS adopted its second opinion, SCCS/1613/19, concluding that aluminium compounds are safe at up to 6.25% elemental aluminium in non-spray deodorants and antiperspirants, 10.60% in spray products, and 2.65% in toothpaste, and that systemic exposure from daily cosmetic use does not add significantly to the body's aluminium burden from other sources, diet being the major one. The committee also noted that aluminium compounds are not skin sensitisers in animal tests and that human sensitisation, where reported, is rare. A later addendum and a further submission extended the assessment to other product categories; the antiperspirant figures above are the ones that have stayed constant through those updates.

In the United States, the FDA's antiperspirant monograph treats these products as drugs, not cosmetics, and its list of permitted actives and ceilings (25% for most chlorohydrate-type salts, 20% for the aluminium zirconium complexes) is the operative limit for products sold there. The Drug Facts panel on a US antiperspirant is therefore doing two jobs at once: it names the active and its percentage, and it carries the kidney-disease warning and the broken-skin warning discussed above. The FDA, like the other major health organisations cited by the American Cancer Society, has not found conclusive evidence linking antiperspirants or their aluminium ingredients to breast cancer.

On the epidemiology, the study that anchors the reassuring side is Mirick, Davis and Thomas (2002) in the Journal of the National Cancer Institute: a population-based case-control study of 813 women with breast cancer and 793 without, which found that the risk of breast cancer did not increase with antiperspirant use (odds ratio 0.9), deodorant use (1.2), product use among women who shaved with a blade razor, or application within one hour of shaving. The study that anchors the worrying side is McGrath (2003), which surveyed 437 women who already had breast cancer and found that more frequent antiperspirant and deodorant use combined with underarm shaving was associated with an earlier age of diagnosis. McGrath's study had no control group of women without cancer, which is why other researchers — including Mirick herself — criticised it as incapable of estimating risk, and why the American Cancer Society describes the overall evidence as limited and mixed, with the larger, better-designed study finding no link. Both studies are reported here because a fair article reports the study that worries people as well as the study that reassures them, with the design difference stated plainly.

On absorption, the number that recurs through the literature is Flarend and colleagues' 2001 tracer study: 84 mg of aluminium-26-labelled aluminium chlorohydrate applied to a single underarm of two volunteers, with blood and urine followed for seven weeks, found that only 0.012% of the applied aluminium was absorbed — about 4 micrograms from a single use on both underarms, about 2.5% of the aluminium typically absorbed from food over the same period. Two volunteers is a small study, and the authors' conclusion was correspondingly narrow: a one-time use does not significantly contribute to the body's aluminium burden. It is not, on its own, a lifetime-exposure study — but it is the reason regulators treat skin as an effective barrier here, and the SCCS's later human study was commissioned precisely to put a stronger number underneath that conclusion.

Advocacy database EWG Skin Deep (labelled here as an advocacy source, not a regulator) lists aluminium chlorohydrate with low concern for cancer and for developmental and reproductive toxicity, moderate concern for use restrictions and for non-reproductive organ-system toxicity, and fair data availability. That profile — low on the headline worry, moderate on the regulatory-restriction flag — is consistent with the regulator position rather than in tension with it, and it is a useful reminder that a hazard-style flag and a risk assessment are different kinds of statement.

The debate

Aluminium compounds are the most contested ingredient on this site, and the contest deserves a fair hearing on both sides, because each side has a real point and each side overstates it somewhere.

The "cleared and safe" view: defenders point to the convergence of the reviews — the SCCS in 2020, the FDA monograph, the American Cancer Society's summary that no major health organisation has found conclusive evidence of a breast-cancer link — to the Mirick case-control study finding no association, to the tiny absorbed fraction in the tracer study, and to the fact that the upper-outer-quadrant geography has a tissue-volume explanation. On this view, the aluminium scare is a textbook case of a plausible mechanism (a metal that interferes with hormone receptors in a dish) being mistaken for a demonstrated human risk, amplified by the fact that the product is applied next to the organ people fear for. The kidney warning, defenders add, is evidence that the system works: a precaution aimed at the one group for whom clearance is genuinely impaired, not a general danger signal.

The "precaution and unanswered questions" view: critics reply that the reassuring evidence has real limits. The epidemiology is almost entirely case-control, which relies on memory of habits years earlier; there is no large prospective cohort following antiperspirant users forward in time. The tracer study had two volunteers and a single application, not a lifetime of daily use on shaved skin. A single published case report describes a woman who used an aluminium antiperspirant daily on shaved skin for four years, developed a plasma aluminium level far above the normal range with bone pain and fatigue, and returned to normal eight months after stopping — a single case that proves nothing on its own, but that critics cite as a reason not to treat the absorption question as closed. And the laboratory findings — metalloestrogen activity in breast cells, aluminium in breast tissue — have not been explained away, only placed in context. On this view, choosing aluminium-free is a reasonable precaution even if it is not a requirement the science imposes, especially since the alternative (a deodorant that manages odour without blocking sweat) costs the user nothing but dryness.

One statistical trap deserves a warning, because it inflates the scare numbers in both directions. A study that finds aluminium in breast tissue, or finds that women who use antiperspirants were diagnosed earlier, is not a study that finds antiperspirants cause breast cancer — the first lacks a comparison group or a causal mechanism in the body, and the second, in McGrath's case, lacks a control group entirely. Equally, a study that finds no association in one population at one time is not proof that no risk exists for anyone at any dose. The honest summary is the middle one, and it is also the least quotable: no causal link established, absorption very low, a few genuine open questions, and a free choice that turns mostly on whether you want to sweat.

Who should avoid them, or ask first

• People with advanced kidney disease — kidneys working at 30% or less: ask your doctor before use, as the US label directs, rather than deciding from the internet
• Anyone with broken, irritated or freshly shaved underarm skin — the labels say not to use antiperspirant there, and irritation is the most common real downside
• People whose underarms react to a particular formula — a rash that clears when the product stops is information, whatever the ingredient, and the stronger chloride formulas are the first suspects
• Anyone booked for a mammogram — skip antiperspirant and deodorant that day, not because of cancer risk, but because aluminium specks on the image can mimic microcalcifications
• People who simply prefer to sweat — a preference needs no scientific justification, and the deodorant guide below is written for exactly that choice

If none of those describe you, aluminium in a compliant antiperspirant is a preference question rather than a health directive — and the spotting section below is how you exercise it either way.

How to spot aluminium compounds on a label

• Aluminium chlorohydrate / aluminum chlorohydrate — the most common active, usually near the top of an antiperspirant list
• Aluminium zirconium trichlorohydrex gly / tetrachlorohydrex gly — the zirconium complexes; the "gly" is glycine, added to soften the formula
• Aluminium sesquichlorohydrate / dichlorohydrate — other members of the same salt family, same job
• Aluminium chloride — the stronger salt, more common in clinical-strength products; more likely to irritate
• On US products, check the Drug Facts panel — the active ingredient and its percentage are stated there, which is more informative than the cosmetic ingredient list on an EU product
• "Aluminium-free" on the front means deodorant, not antiperspirant — if it blocks sweat, it contains an aluminium salt; if it contains no aluminium salt, it manages odour only

Alternatives: odour control without blocking sweat

Avoiding aluminium is straightforward, because the alternative category already exists and is well stocked: deodorants. The trade is explicit and should be stated without softening it — a deodorant will not keep you dry. What it does is manage odour, through antibacterial ingredients, odour absorbers such as magnesium hydroxide and zinc ricinoleate, and absorbent starches, with baking soda (sodium bicarbonate) as the strongest and most irritating of the common options. Our deodorant guide works through that trade in full, including the baking-soda irritation issue that catches many switchers and the two-to-four-week adjustment as underarm bacteria rebalance.

Two practical notes from that guide are worth repeating here. First, many people end up using both categories for different jobs — antiperspirant for events and heavy days, aluminium-free deodorant for ordinary days — and there is nothing inconsistent about that, since the categories are tools, not teams. Second, the "detox period" so often marketed to switchers is a real adjustment with a misleading name: there is no toxin purge involved, only microbiology and habit, but the temporary extra odour during the first weeks is genuine. And as with every preservative-free claim elsewhere on this site, a product whose only virtue is what it leaves out should still be judged on what it put in instead — a baking-soda deodorant that gives you a rash has not improved your situation by being aluminium-free.

Checked against SCCS opinions SCCS/1525/14 and SCCS/1613/19, 21 CFR Part 350, the American Cancer Society, the National Kidney Foundation, Mirick et al. 2002, McGrath 2003, Darbre 2005, Exley et al. 2007, Flarend et al. 2001, and the EWG Skin Deep database (an advocacy source) · Last updated 2026-10-27 · How we assess ingredients

Read more

Best Deodorant Without Aluminium: What Actually Works, and What to ExpectParabens: What They Are, Why People Avoid Them, and What the Evidence SaysPhenoxyethanol: The Everyday Preservative Behind the Baby-Product Debate